Navigation Links
ARIUS announces second quarter fiscal 2008 financial results
Date:7/11/2008

473,080 387,674

-----------------------------------------------------------------------

9,801,876 13,478,355

Facilities and equipment, net 1,763,960 1,889,921

-------------------------------------------------------------------------

11,565,836 15,368,276

-------------------------------------------------------------------------

-------------------------------------------------------------------------

Liabilities and Shareholders' Equity

Current liabilities:

Accounts payable and accrued liabilities 2,060,753 2,034,972

Accrued loss on embedded foreign exchange

derivative 129,930 296,064

Current portion of leasehold inducements 41,484 41,484

Current portion of capital lease obligation 15,304 25,710

Current portion of deferred revenue 1,746,767 1,991,413

-----------------------------------------------------------------------

3,994,238 4,389,643

Leasehold inducements 214,548 235,291

Capital lease obligation - 2,224

Deferred revenue 1,752,104 1,758,898

Shareholders' equity:

Share capital:

Common shares 31,084,346 28,644,454

Warrants 10,325,740 9,603,644

Compensation warrants - 912,377

Contributed surplus 3,129,511 2,355,378

Deficit (38,934,651) (32,533,633)

------------------------------------------
'/>"/>

SOURCE ARIUS Research Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. ARIUS presents new findings for anti-cancer antibody programs at AACR
2. ARIUS announces first quarter fiscal 2008 financial results
3. ARIUS 2008 Annual and Special Meeting of Shareholders
4. ARIUS recognized for entrepreneurial excellence
5. ARIUS announces five abstracts selected for presentation at 2008 AACR Annual Meeting
6. ARIUS presents new findings showing therapeutic antibody inhibits human leukemic cancer stem cells
7. Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody
8. ARIUS announces manufacturing Agreement with Laureate Pharma For Trop-2 targeting antibody
9. ARIUS announces fourth quarter and year-end fiscal 2007 financial results
10. Arius completes Pre-IND Meeting with FDA for Lead CD44 Cancer Stem Cell Program
11. ARIUS to Hold Fourth Quarter and Year End 2007 Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... 2013 Venaxis, Inc. (Nasdaq:   APPY), an ... FDA clearance and commercializing its rapid, protein biomarker-based appendicitis ... an underwritten public offering of 10,000,000 shares of its ... of its common stock at an exercise price of ... of $1.25 per share and related warrant.  Venaxis has ...
(Date:5/23/2013)... 23, 2013 Patheon Inc ., ... to the global pharmaceutical industry, will host a complimentary ... to Testing” on Tuesday, June 4, 2013 at 11 ... are required to comply with regulations for cleaning validation. ... limited scientific underpinning and little evaluation of risk. ...
(Date:5/23/2013)... 23, 2013 PI’s new LPS-24 ... provide 15 mm travel range with closed-loop sensor ... dimensions make these new positioners the ideal choice ... vacuum rated version is also available. , ... datasheets can be found at: , http://www.physikinstrumente.com/en/products/prdetail.php?sortnr=1000745&prw-lps24 ...
(Date:5/23/2013)... May 23, 2013 BioTrends Research Group, ... firms for specialized biopharmaceutical issues, finds that, unaided, ... disease specialists reported that in the past six ... delaying treatment) in anticipation of the next generation ... ago, when only 6 percent reported that they ...
Breaking Biology Technology:Venaxis Announces Pricing of Offering of Common Stock and Warrants 2Venaxis Announces Pricing of Offering of Common Stock and Warrants 3Patheon to Present on “Cleaning Validation: Science, Risk and Novel Approaches to Testing” 2Precision Positioning System Uses Miniaturezed Piezo Linear Motor: LPS-24 Linear Stage by PI 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 2The Majority of Physicians that Treat Hepatitis C Virus (HCV) Have Begun "Warehousing" and Preparing Their HCV Patients for the Next Generation of HCV Treatments 3
... 20, 2010 ... ... --> ... // Results are keyed by longUrl, so we need to grab the first one. for (var r in data.results) ...
... SAN DIEGO, Oct. 19, 2010 Amylin Pharmaceuticals, Inc. ... net product sales for the quarter ended September 30, ... the quarter include $132.4 million for BYETTA® (exanatide) injection ... compares to net product sales of $192.9 million consisting ...
... 19, 2010 -- The Cold Triple Axis spectrometer, a ... Isotope Reactor and a complementary tool to other neutron ... The CTAX uses "cold" neutrons from the HFIR ... Cold neutrons are slower than their "thermal" neutron counterparts, ...
Cached Biology Technology:JIPH Accepted for MEDLINE Indexing 2JIPH Accepted for MEDLINE Indexing 3JIPH Accepted for MEDLINE Indexing 4JIPH Accepted for MEDLINE Indexing 5JIPH Accepted for MEDLINE Indexing 6JIPH Accepted for MEDLINE Indexing 7JIPH Accepted for MEDLINE Indexing 8JIPH Accepted for MEDLINE Indexing 9ORNL's research reactor revamps veteran neutron scattering tool 2
(Date:5/24/2013)... for medication against Alzheimer,s disease, scientists have focused among ... beta (A-beta). After all, it is the accumulation of A-beta ... patients. Starting point for the formation of A-beta is APP. ... to unravel the function of APPL the fruit-fly version ... , Alessia Soldano (VIB/KU Leuven): "We have discovered that ...
(Date:5/23/2013)... to be the world,s most popular fruit, can be ... with purple GM varieties. , "Working with GM ... the addition of a specific compound, allows us to ... Professor Cathie Martin from the John Innes Centre. , ... better flavour, health and shelf life characteristics because even ...
(Date:5/23/2013)... School of Public Health at Emory University, along ... have received a $4 million grant over four ... University (Health and Exposome Research Center: Understanding Lifetime ... grant awarded in the United States. , ... Institute of Environmental Health Sciences (NIEHS) of the ...
Breaking Biology News(10 mins):A new strategy required in the search for Alzheimer's drugs? 2The world's favorite fruit only better-tasting and longer-lasting 2Emory, Georgia Tech receive first human exposome center grant in US 2Emory, Georgia Tech receive first human exposome center grant in US 3
... , , , , , ... AUDIO: When men outnumber women, the women tend to marry younger and men engage in ... , , , , , ... , , , , , , , , ANN ARBOR, Mich..---When men outnumber ...
... Boston University biomedical engineering researchers has won a $4.1 ... to refine its nanoscale, low-cost, ultra-fast DNA sequencing method ... than $1,000. Developed in the past four ... led by Boston University Biomedical Engineering Professor Amit Meller, ...
... variations in nuclear decay rates have led some to ... the relative ages of rocks and organic materials. Scientists ... working with researchers from Purdue University, the University of ... the hypothesis that solar radiation might affect the rate ...
Cached Biology News:Women: Hope to marry young? Head to Alaska, steer clear of Alabama 2Women: Hope to marry young? Head to Alaska, steer clear of Alabama 3Women: Hope to marry young? Head to Alaska, steer clear of Alabama 4BU team wins $4.1M genome grant 2Research shows radiometric dating still reliable (again) 2
... Certified USDA Research Registered OLAW Assured AAALAC ... AALAS Certified Technicians Documentation ... Upon Request Focus CRP is ... your custom immunology service needs. We ...
...
Applications: Western blotting ...
...
Biology Products: